These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24469600)

  • 1. Prandial effect on the systemic exposure of amisulpride.
    Jang YJ; Jeong TC; Noh K; Baek IW; Kwon KI; Kim E; Yoon YR; Kang W
    Arch Pharm Res; 2014 Oct; 37(10):1325-8. PubMed ID: 24469600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and pharmacokinetics of a single oral dose of amisulpride in healthy elderly volunteers.
    Hamon-Vilcot B; Chaufour S; Deschamps C; Canal M; Zieleniuk I; Ahtoy P; Chretien P; Rosenzweig P; Nasr A; Piette F
    Eur J Clin Pharmacol; 1998 Jul; 54(5):405-9. PubMed ID: 9754984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single oral doses of amisulpride do not enhance the effects of alcohol on the performance and memory of healthy subjects.
    Mattila MJ; Patat A; Seppälä T; Kalska H; Jalava ML; Vanakoski J; Lavanant C
    Eur J Clin Pharmacol; 1996; 51(2):161-6. PubMed ID: 8911882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability study of amisulpride tablets in healthy Indian volunteers.
    Das A; Bhaumik U; Chakrabarty US; Sarkar AK; Ghosh A; Bose A; Chatterjee B; Pal TK
    Arzneimittelforschung; 2009; 59(4):166-70. PubMed ID: 19517892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
    J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of amisulpride in rat plasma by HPLC-MS/MS.
    Noh K; Jang YJ; Kwon KI; Kim E; Jeong TC; Yun HY; Kang W
    Arch Pharm Res; 2015 Jan; 38(1):63-7. PubMed ID: 24619919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Müller MJ; Eich FX; Regenbogen B; Sachse J; Härtter S; Hiemke C
    J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring.
    Gschwend MH; Arnold P; Ring J; Martin W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):132-9. PubMed ID: 16386474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
    Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C
    Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of enantiomers of sultopride in a human, rats and rabbits.
    Kamizono A; Inotsume N; Fukushima S; Nakano M
    Biol Pharm Bull; 1993 Nov; 16(11):1121-3. PubMed ID: 7906175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fatal intoxication with amisulpride and presentation of organ distribution].
    Musshoff F; Kröner L; Padosch SA; Madea B
    Arch Kriminol; 2005; 215(5-6):158-63. PubMed ID: 15991733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects.
    Patat A; Rosenzweig P; Miget N; Allain H; Gandon JM
    Fundam Clin Pharmacol; 1999; 13(5):582-94. PubMed ID: 10520732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
    Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication.
    Péhourcq F; Ouariki S; Bégaud B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(1):101-5. PubMed ID: 12726848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.
    Möller HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1101-11. PubMed ID: 14642970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.
    Sparshatt A; Taylor D; Patel MX; Kapur S
    Acta Psychiatr Scand; 2009 Dec; 120(6):416-28. PubMed ID: 19573049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers.
    Wetzel H; Wiesner J; Hiemke C; Benkert O
    J Psychiatr Res; 1994; 28(5):461-73. PubMed ID: 7897617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.